Pfizer Inc. recalled 29,004 bottles of Levoxyl on July 29, 2025, due to subpotency. The recall affects levothyroxine sodium tablets, 50 mcg, Rx only, distributed in the U.S. Consumers should stop using the product immediately.
Subpotent drug
Consumers and healthcare providers should stop using this product immediately. Contact Pfizer or your healthcare provider for guidance. Notification method: Letter
The recall involves Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, in 100-count bottles. The lot number is 24C11, and it expires on February 28, 2026.
Levoxyl may not contain the intended potency of levothyroxine sodium, which can lead to insufficient thyroid hormone levels. This is classified as a Class II recall, indicating a potential for temporary health issues.
No specific incidents or injuries have been reported related to this recall. The risk remains high due to the potential for untreated thyroid conditions.
Stop using Levoxyl immediately. Contact your healthcare provider for further guidance and instructions on returning the product.
For questions, call Pfizer at 1-800-XXX-XXXX or visit their website at www.pfizer.com. Additional recall information is available through the FDA.
Abiomed issued a recall for 10,153 Automated Impella Controllers on October 1, 2025. The devices face potential cybersecurity vulnerabilities related to their operating system. Healthcare providers and patients should stop using these devices immediately.
Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.
AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.